{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:35:49Z","timestamp":1794335749457,"version":"4.9.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T00:00:00Z","timestamp":1483401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["42387"],"award-info":[{"award-number":["42387"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1055855"],"award-info":[{"award-number":["OPP1055855"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1130379"],"award-info":[{"award-number":["OPP1130379"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Human and Health Services","award":["5R21AI109118"],"award-info":[{"award-number":["5R21AI109118"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.vaccine.2016.12.057","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T10:53:10Z","timestamp":1484218390000},"page":"916-922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica"],"prefix":"10.1016","volume":"35","author":[{"given":"Mayuresh M.","family":"Abhyankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zannatun","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Tomai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Elvecrog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William A.","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.12.057_b0005","unstructured":"WHO. WHO fact sheet N0 330. Diarrheal disease. WHO; 2013."},{"issue":"6","key":"10.1016\/j.vaccine.2016.12.057_b0010","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/ije\/30.6.1457","article-title":"Early childhood diarrhoea and helminthiases associate with long-term linear growth faltering","volume":"30","author":"Moore","year":"2001","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.12.057_b0015","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1172\/JCI34005","article-title":"Enteric infections, diarrhea, and their impact on function and development","volume":"118","author":"Petri","year":"2008","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.vaccine.2016.12.057_b0020","doi-asserted-by":"crossref","first-page":"e18891","DOI":"10.1371\/journal.pone.0018891","article-title":"T cell responses to the RTS, S\/AS01(E) and RTS, S\/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children","volume":"6","author":"Ansong","year":"2011","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2016.12.057_b0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2051013614541440","article-title":"Liposomes as vaccine delivery systems: a review of the recent advances","volume":"2","author":"Schwendener","year":"2014","journal-title":"Ther Adv Vacc"},{"issue":"12","key":"10.1016\/j.vaccine.2016.12.057_b0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-3155-12-17","article-title":"A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7","volume":"26","author":"Fox","year":"2014","journal-title":"J Nanobiotechnol"},{"issue":"33 Suppl 2","key":"10.1016\/j.vaccine.2016.12.057_b0035","doi-asserted-by":"crossref","first-page":"B14","DOI":"10.1016\/j.vaccine.2015.01.088","article-title":"New generation adjuvants\u2013from empiricism to rational design","volume":"8","author":"O\u2019Hagan","year":"2015","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2016.12.057_b0040","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1128\/IAI.01527-07","article-title":"Immunization with a Toll-like receptor 7 and\/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB\/c mice","volume":"76","author":"Zhang","year":"2008","journal-title":"Infect Immun"},{"issue":"9888","key":"10.1016\/j.vaccine.2016.12.057_b0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet Lond Engl"},{"issue":"11","key":"10.1016\/j.vaccine.2016.12.057_b0050","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.trstmh.2005.12.012","article-title":"Entamoeba histolytica-associated diarrheal illness is negatively associated with the growth of preschool children: evidence from a prospective study","volume":"100","author":"Mondal","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.vaccine.2016.12.057_b0055","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.4161\/hv.27796","article-title":"The future for vaccine development against Entamoeba histolytica","volume":"10","author":"Quach","year":"2014","journal-title":"Hum Vacc Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2016.12.057_b0060","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/IAI.02490-14","article-title":"Immunization with the Entamoeba histolytica surface metalloprotease EhMSP-1 protects hamsters from amebic liver abscess","volume":"83","author":"Roncolato","year":"2015","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2016.12.057_b0065","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.vaccine.2013.06.056","article-title":"Expression, purification, and evaluation of recombinant LecA as a candidate for an amebic colitis vaccine","volume":"32","author":"Barroso","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.12.057_b0070","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu Rev Immunol"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2016.12.057_b0075","doi-asserted-by":"crossref","first-page":"C2","DOI":"10.1016\/j.vaccine.2010.07.022","article-title":"Key concepts in immunology","volume":"28","author":"Moser","year":"2010","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2016.12.057_b0080","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1086\/320740","article-title":"Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children","volume":"183","author":"Haque","year":"2001","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2016.12.057_b0085","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4269\/ajtmh.2007.76.340","article-title":"Correlation of interferon-gamma production by peripheral blood mononuclear cells with childhood malnutrition and susceptibility to amebiasis","volume":"76","author":"Haque","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"10.1016\/j.vaccine.2016.12.057_b0090","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1128\/IAI.00487-09","article-title":"Protection against intestinal amebiasis by a recombinant vaccine is transferable by T cells and mediated by gamma interferon","volume":"77","author":"Guo","year":"2009","journal-title":"Infect Immun"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2016.12.057_b0095","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.vaccine.2003.09.003","article-title":"Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal\/GalNac lectin","volume":"22","author":"Houpt","year":"2004","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.vaccine.2016.12.057_b0100","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1016\/j.vaccine.2013.09.069","article-title":"TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses","volume":"31","author":"Fox","year":"2013","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2016.12.057_b0105","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1002\/jps.23307","article-title":"Characterization of TLR4 agonist effects on alhydrogel\u00ae sedimentation: a novel application of laser scattering optical profiling","volume":"101","author":"Fox","year":"2012","journal-title":"J Pharm Sci"},{"issue":"113","key":"10.1016\/j.vaccine.2016.12.057_b0110","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.colsurfb.2013.09.006","article-title":"In vitro evaluation of TLR4 agonist activity: formulation effects","volume":"1","author":"Misquith","year":"2014","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"33","key":"10.1016\/j.vaccine.2016.12.057_b0115","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1016\/j.vaccine.2011.05.061","article-title":"Vaccine adjuvant activity of 3M\u2013052: an imidazoquinoline designed for local activity without systemic cytokine induction","volume":"29","author":"Smirnov","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2016.12.057_b0120","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0035-9203(78)90144-X","article-title":"A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba","volume":"72","author":"Diamond","year":"1978","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2016.12.057_b0125","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/infdis\/171.3.645","article-title":"A recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin is efficacious as a subunit vaccine in the gerbil model of amebic liver abscess","volume":"171","author":"Soong","year":"1995","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2016.12.057_b0130","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1172\/JCI110377","article-title":"Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes","volume":"68","author":"Ravdin","year":"1981","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.vaccine.2016.12.057_b0135","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1038\/emi.2013.58","article-title":"IL-17 cytokines in immunity and inflammation","volume":"2","author":"Jin","year":"2013","journal-title":"Emerg Microbes Infect"},{"issue":"33","key":"10.1016\/j.vaccine.2016.12.057_b0140","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1016\/j.vaccine.2012.05.049","article-title":"Immune markers and correlates of protection for vaccine induced immune responses","volume":"30","author":"Thakur","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2016.12.057_b0145","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.vaccine.2010.11.013","article-title":"CD4+ and CD8+ T cell- and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine","volume":"29","author":"Guo","year":"2011","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2016.12.057_b0150","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1172\/JCI44262","article-title":"Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunization in mice","volume":"121","author":"Hammerschmidt","year":"2011","journal-title":"J Clin Invest"},{"issue":"16","key":"10.1016\/j.vaccine.2016.12.057_b0155","doi-asserted-by":"crossref","first-page":"8316","DOI":"10.1128\/JVI.00781-11","article-title":"Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge","volume":"85","author":"Tan","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.12.057_b0160","article-title":"Current status of TLR4 ligand vaccine adjuvants, immunopotentiators","author":"Fox","year":"2016"},{"key":"10.1016\/j.vaccine.2016.12.057_b0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2051-1426-2-12","article-title":"Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors","volume":"2","author":"Zhao","year":"2014","journal-title":"J Immunother Cancer"},{"issue":"9","key":"10.1016\/j.vaccine.2016.12.057_b0170","first-page":"4722","article-title":"Effective innate and adaptive antimelanoma immunity through localized TLR7\/8 activation","volume":"193","author":"Singh","year":"2014","journal-title":"J Immunol Baltim Md 1950"},{"key":"10.1016\/j.vaccine.2016.12.057_b0175","doi-asserted-by":"crossref","unstructured":"Orr MT, Fox CB, Baldwin SL, Sivananthan SJ, Lucas E, Lin S, et al. Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis. J Control Release Off J Control Release Soc [Internet]; 2013 November 28 [cited 2016 Feb 11], 172(1). Available from: <http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3871206\/>.","DOI":"10.1016\/j.jconrel.2013.07.030"},{"issue":"2","key":"10.1016\/j.vaccine.2016.12.057_b0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/mi.2007.18","article-title":"Persistence of Entamoeba histolytica infection in CBA mice owes to intestinal IL-4 production and inhibition of protective IFN-gamma","volume":"1","author":"Guo","year":"2008","journal-title":"Mucosal Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.12.057_b0185","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/mi.2014.111","article-title":"Cholera toxin adjuvant promotes a balanced Th1\/Th2\/Th17 response independently of IL-12 and IL-17 by acting on Gs\u03b1 in CD11b+ DCs","volume":"8","author":"Mattsson","year":"2015","journal-title":"Mucosal Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.12.057_b0190","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.immuni.2011.03.003","article-title":"Essential role for retinoic acid in the promotion of CD4+ T cell effector responses via retinoic acid receptor alpha","volume":"34","author":"Hall","year":"2011","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.vaccine.2016.12.057_b0195","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1574-695X.2002.tb00551.x","article-title":"Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA","volume":"32","author":"McCluskie","year":"2002","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.12.057_b0200","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jconrel.2012.07.039","article-title":"Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations","volume":"162","author":"Pattani","year":"2012","journal-title":"J Control Release"},{"issue":"8","key":"10.1016\/j.vaccine.2016.12.057_b0205","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.12.057_b0210","doi-asserted-by":"crossref","unstructured":"Fiorino F, Pettini E, Pozzi G, Medaglini D, Ciabattini A. Prime-boost strategies in mucosal immunization affect local IgA production and the type of Th response. Front Immunol [Internet]; 2013 May 29 [cited 2016 Feb 11];4. Available from: <http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3665932\/>.","DOI":"10.3389\/fimmu.2013.00128"},{"issue":"5802","key":"10.1016\/j.vaccine.2016.12.057_b0215","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1132742","article-title":"Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells","volume":"314","author":"Mora","year":"2006","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.vaccine.2016.12.057_b0220","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/j.vaccine.2012.02.066","article-title":"Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.)","volume":"30","author":"Abd Alla","year":"2012","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2016.12.057_b0225","doi-asserted-by":"crossref","first-page":"e7302","DOI":"10.1371\/journal.pone.0007302","article-title":"Randomized controlled trial of RTS, S\/AS02D and RTS, S\/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children","volume":"4","author":"Owusu-Agyei","year":"2009","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.vaccine.2016.12.057_b0230","first-page":"2953","article-title":"Modulation of T cell and innate immune responses by retinoic acid","volume":"192","author":"Raverdeau","year":"2014","journal-title":"J Immunol Baltim Md 1950"},{"issue":"1671","key":"10.1016\/j.vaccine.2016.12.057_b0235","doi-asserted-by":"crossref","first-page":"20140145","DOI":"10.1098\/rstb.2014.0145","article-title":"Potential for use of retinoic acid as an oral vaccine adjuvant","volume":"370","author":"Mwanza-Lisulo","year":"2015","journal-title":"Phil Trans R Soc B"},{"issue":"1","key":"10.1016\/j.vaccine.2016.12.057_b0240","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.smim.2008.08.004","article-title":"Augmentation of antibody responses by retinoic acid and costimulatory molecules","volume":"21","author":"Ross","year":"2009","journal-title":"Semin Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16312907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16312907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T08:56:16Z","timestamp":1568710576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16312907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0264410X16312907"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}